Primary Record
methysergide
- In stock
- 4,032 g
- Purity
- 98.9 %
- CAS
- 361-37-5
Compound Identifiers & Properties
- CAS
- 361-37-5
- PubChem CID
- 9681
- SMILES
- CC[C@@H](CO)NC(=O)[C@H]1CN([C@@H]2CC3=CN(C4=CC=CC(=C34)C2=C1)C)C
- Canonical SMILES
- CC[C@@H](CO)NC(=O)[C@@H]1C=C2c3cccc4c3c(cn4C)C[C@H]2N(C)C1
Names & Synonyms
- methysergide
- Methysergid
- Deseril
- Sansert
- Desernil
- Deseryl
- Desernyl
- Methysergidum
- Metisergide
- Metisergido
- Desril
- metisergida
- Dimethylergometrin
- Methysergide maleate
- Metisergide [DCIT]
- 1-Methylmethylergonovine
- Desernil Sandoz
- Methylmethylergonovine
- Methysergidum [INN-Latin]
- Metisergido [INN-Spanish]
- Deseril (TN)
- Sansert (TN)
- Methyllysergic acid butanolamide
- Maleate, Methysergide
- Methysergide dimaleate
- UML-491
- 361-37-5
- Dimaleate, Methysergide
- XZA9HY6Z98
- UML 491
- Methysergide (USAN/INN)
- Methysergide [USAN:INN:BAN]
- UNII-XZA9HY6Z98
- AC1L1TKV
- RefChem:818760
- CHEMBL1065
- METHYSERGIDE [MI]
- DTXSID2023307
- METHYSERGIDE [INN]
- Biomol-NT_000155
- D0O6GC
- 1-Methyl-D-lysergic acid butanolamide
- HSDB 3237
- METHYSERGIDE [HSDB]
- METHYSERGIDE [USAN]
- DTXCID703307
- 1-Methyllysergic acid butanolamide
- Methylergometrine EP impurity G
- METHYSERGIDE [VANDF]
- Lopac0_000863
- SB 202190 Hydrochloride
- SCHEMBL41843
- GTPL134
- METHYSERGIDE [MART.]
- MLS000069364
- METHYSERGIDE [WHO-DD]
- EINECS 206-644-0
- BPBio1_000486
- C21H27N3O2
- Methysergide [USAN:BAN:INN]
- UML491
- BDBM30708
- CHEBI:92629
- cid_5281073
- BRN 0765985
- CID9681
- N02CA04
- CHEBI:584020
- KPJZHOPZRAFDTN-ZRGWGRIASA-N
- HMS2090P04
- Tox21_110895
- BDBM50031942
- NCGC00024027-05
- ZINC53151228
- C21-H27-N3-O2
- Tox21_110895_1
- CCG-204945
- FM31590
- SDCCGSBI-0050838.P003
- N-(1-(Hydroxymethyl)propyl)-1-methyl-dextro-(+)-lysergamide
- N-(alpha-(Hydroxymethyl)propyl)-1-methyl-dextro-lysergamide
- (+)-N-(1-(Hydroxymethyl)propyl)-1-methyl-D-lysergamide
- NCGC00024027-04
- NCGC00024027-06
- NCGC00024027-07
- NCGC00024027-08
- NCGC00024027-09
- NCGC00024027-13
- 1-Methyl-dextro-lysergic acid (+)-1-hydroxy-2-butylamide
- CAS-361-37-5
- J76.430B
- LS-64361
- SMR000058483
- SBI-0050838.P002
- NS00001621
- C07199
- D02357
- Lysergamide, N-(1-(hydroxymethyl)propyl)-1-methyl-, D-
- 9,10-Didehydro-N-(1-(hydroxymethyl)propyl)-1,6-dimethylergoline-8-carboxamide
- AB00513725-14
- AB00513725_15
- (+)-9,10-Didehydro-N-(1-(hydroxymethyl)propyl)-1,6-dimethylergoline-8beta-carboxamide
- Q424442
- (6aR,9R)-N-[(2S)-1-hydroxybutan-2-yl]-4,7-dimethyl-6,6a,8,9-tetrahydroindolo[4,3-fg]quinoline-9-carboxamide
- ERGOMETRINE MALEATE IMPURITY G [EP IMPURITY]
- N-[1-(hydroxymethyl)propyl]-1-methyl-D-lysergamide
- BRD-K35941380-001-01-7
- BRD-K35941380-050-17-0
- BRD-K35941380-050-27-9
- Ergoline-8-carboxamide, 9,10-didehydro-N-(1-(hydroxymethyl)propyl)-1,6-dimethyl-, (8beta)-
- Ergoline-8beta-carboxamide, 9,10-didehydro-N-(1-(hydroxymethyl)propyl)-1,6-dimethyl-
- Methylergometrine Maleate EP Impurity G; Methysergide
- Ergoline-8-carboxamide, 9,10-didehydro-N-(1-(hydroxymethyl)propyl)-1,6-dimethyl-, (8beta(S))-
- (8alpha)-N-[(2S)-1-hydroxybutan-2-yl]-1,6-dimethyl-9,10-didehydroergoline-8-carboxamide
- (8beta)-9,10-Didehydro-N-[(1S)-1-(hydroxymethyl)propyl]-1,6-dimethylergoline-8-carboxamide
- (8beta)-N-[(1S)-1-(hydroxymethyl)propyl]-1,6-dimethyl-9,10-didehydroergoline-8-carboxamide
- Ergoline-8-beta-carboxamide, 9,10-didehydro-N-(1-(hydroxymethyl)propyl)-1,6-dimethyl-
- (6aR,9R)-N-[(2S)-1-hydroxybutan-2-yl]-4,7-dimethyl-6,6a,8,9-
- (8beta)-N-[(2S)-1-Hydroxybutan-2-yl]-1,6-dimethyl-9,10-didehydroergoline-8-carboxamide
- 9,10-Didehydro-N-[(S)-1-(hydroxymethyl)propyl]-1,6-dimethylergoline-8beta-carboxamide
- N-[(2S)-1-Hydroxybutan-2-yl]-1,6-dimethyl-9,10-didehydroergoline-8beta-carboxamide
- (+)-N-[1-(Hydroxymethyl)propyl]-1-methyl-D-lysergamide; Deseril; Desernyl; Deseryl; Methysergid; Methysergide; UML 491; (8beta)-9,10-Didehydro-N-[(1S)-1-(hydroxymethyl)propyl]-1,6-dimethylergoline-8-carboxamide; Indolo[4,3-fg]quinoline Ergoline-8-carboxamide Deriv.; D-N-[1-(Hydroxymethyl)propyl]-1-methyl-lysergamide; 9,10-Didehydro-N-[1-(hydroxymethyl)propyl]-1,6-dimethyl-ergoline-8beta-carboxamide; [8beta(S)]-,10-Didehydro-N-[1-(hydroxymethyl)propyl]-1,6-dimethyl-ergoline-8-carboxamide; Methylergonovine EP Impurity G;
- (4R,7R)-N-((2S)-1-hydroxybutan-2-yl)-6,11-dimethyl-6,11-diazatetracyclo(7.6.1.0^(2,7).0^(12,16))hexadeca-1(16),2,9,12,14-pentaene-4-carboxamide
- (4R,7R)-N-(1-hydroxybutan-2-yl)-6,11-dimethyl-6,11-diazatetracyclo(7.6.1.02,7.012,16)hexadeca-1(15),2,9,12(16),13-pentaene-4-carboxamide
- (4R,7R)-N-[(2S)-1-hydroxybutan-2-yl]-6,11-dimethyl-6,11-diazatetracyclo[7.6.1.0^{2,7}.0^{12,16}]hexadeca-1(16),2,9,12,14-pentaene-4-carboxamide
- (4R,7R)-N-[(2S)-1-hydroxybutan-2-yl]-6,11-dimethyl-6,11-diazatetracyclo[7.6.1.02,7.012,16]hexadeca-1(16),2,9,12,14-pentaene-4-carboxamide
- (6aR,9R)-4,6a,7-Trimethyl-4,6,6a,7,8,9-hexahydro-indolo[4,3-fg]quinoline-9-carboxylic acid (1-hydroxymethyl-propyl)-amide
- (6aR,9R)-4,7-Dimethyl-4,6,6a,7,8,9-hexahydro-indolo[4,3-fg]quinoline-9-carboxylic acid ((S)-1-hydroxymethyl-propyl)-amide
- (6aR,9R)-4,7-dimethyl-N-[(1S)-1-methylolpropyl]-6,6a,8,9-tetrahydroindolo[4,3-fg]quinoline-9-carboxamide;maleate
- (6aR,9R)-4,7-dimethyl-N-[(1S)-1-methylolpropyl]-6,6a,8,9-tetrahydroindolo[4,3-fg]quinoline-9-carboxamide;maleic acid
- (6aR,9R)-4,7-dimethyl-N-[(2S)-1-oxidanylbutan-2-yl]-6,6a,8,9-tetrahydroindolo[4,3-fg]quinoline-9-carboxamide;(Z)-but-2-enedioic acid
- (6aR,9R)-4-Methyl-4,6,6a,7,8,9-hexahydro-indolo[4,3-fg]quinoline-9-carboxylic acid (1-hydroxymethyl-propyl)-amide
- (6aR,9R)-5,7-Dimethyl-4,6,6a,7,8,9-hexahydro-indolo[4,3-fg]quinoline-9-carboxylic acid diethylamide
- (6aR,9R)-N-((1S)-1-(hydroxymethyl)propyl)-4,7-dimethyl-6,6a,8,9-tetrahydroindolo(4,3-fg)quinoline-9-carboxamide
- (6aR,9R)-N-((S)-1-hydroxybutan-2-yl)-4,7-dimethyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide
- (6aR,9R)-N-[(1S)-1-(hydroxymethyl)propyl]-4,7-dimethyl-6,6a,8,9-tetrahydroindolo[4,3-fg]quinoline-9-carboxamide
- (6aR,9R)-N-[(2S)-1-hydroxybutan-2-yl]-4,7-dimethyl-6,6a,8,9-tetrahydroindolo[4,3-fg]quinoline-9-carboxamide;(Z)-2-butenedioic acid
- (6aR,9R)-N-[(2S)-1-hydroxybutan-2-yl]-4,7-dimethyl-6,6a,8,9-tetrahydroindolo[4,3-fg]quinoline-9-carboxamide;(Z)-but-2-enedioic acid
- (8-beta)-9,10-Didehydro-N-[(1S)-1-(hydroxymethyl)propyl]-1,6-dimethylergoline-8-carboxamide
- (methylsergide)4,7-Dimethyl-4,6,6a,7,8,9-hexahydro-indolo[4,3-fg]quinoline-9-carboxylic acid (1-hydroxymethyl-propyl)-amide
- 206-644-0
- 350228-36-3
- 4,7-Dimethyl-4,6,6a,7,8,9-hexahydro-indolo[4,3-fg]quinoline-9-carboxylic acid (1-hydroxymethyl-propyl)-amide
- H8J